The STCC Unified PD1/PDL1 Evaluation of Response (SUPER) study is a collaborative research effort led by the Singapore Translational Cancer Consortium (STCC) aimed at identifying biomarkers that ...

A study featuring investigators from the University at Buffalo Clinical and Translational Science Institute (CTSI), Roswell Park Comprehensive Cancer Center, and CTSA (Clinical and Translational ...

MARLBOROUGH, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (“Akoya”), The Spatial Biology Company ®, today announced a collaboration with the Singapore Translational Cancer ...

OrigAMI-2: A randomized, phase 3 study of amivantamab vs cetuximab, both in combination with FOLFOX or FOLFIRI, as first-line treatment in left-sided RAS/BRAF wild-type metastatic colorectal cancer.

Pilot study of CBX-12 pharmacodynamics in patients with advanced solid tumors. Background: The gut microbiome (GM) is thought to influence host immunity by modulating multiple immunologic pathways.

In KRAS mutant 2L mCRC, pelareorep delivers prolonged survival benefit with a median PFS and median OS approximately 2.5x the current standard of care Translational data from multiple studies confirm ...

A new study published in Translational Psychiatry suggests that Major Depressive Disorder (MDD) may be linked to unusual changes in how the body’s cells produce and manage energy. The ...

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. The gas xenon, like the other noble, or inert, gases, is known for ...